JPRN-jRCT2080220422未知3 期
Phase 3 clinical trial of a combination of MGV-5 and AS-4370 as pretreatment for barium enema X-ray radiography
Ajinomoto Pharmaceuticals Co., Ltd.0 个研究点开始时间: 2007年8月3日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Major inclusion criteria:
- •Persons aged >=20 and <75 years scheduled to undergo Barium enema X-ray examination.
- •Major exclusion criteria:
- •Persons who have or are suspected of having gastrointestinal obstruction or intestinal obstruction.
- •Persons who have intestinal perforation.
- •Persons who have toxic megacolon.
排除标准
- 未提供
研究者
相似试验
招募中
2 期
GcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III.Breast cancer IIa, IIb and IIIa surgically treated with positive gangliaBreast NeoplasmsBreast DiseasesRPCEC00000070Center of Molecular Immunology (CIM)744
进行中（未招募）
不适用
A phase III clinical trial comparing infusional 5-Fluorouracil (5-FU), Leucovorin and Oxaliplatin (mFOLFOX -6) every 2 weeks with Bevacizumab to the same regimen without Bevacizumab for the treatment of patients with resected stages two and three carcinoma of the colon.Resected stage II or stage III adenocarcinoma of the colonEUCTR2005-000331-14-IEAll Ireland Cooperative Oncology Research Group2,632
未知
3 期
MK-0431/ONO-5435 Phase III Clinical Study - Glimepiride add-on Study for Patients with Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-jRCT2080220288ONO PHARMACEUTICAL CO.,LTD.
进行中（未招募）
不适用
Pivotal phase III trial to investigate the efficacy and safety of an Orodispersible Tablet vardenafil versus placebo in the treatment of men with Erectile dysfunction (ED) - a fixed-dose, double-blind, raNdomized multi-center Trial - POTENT I - POTENT IErectile Dysfunction (ED)MedDRA version: 9.1Level: LLTClassification code 10061461Term: Erectile dysfunctionEUCTR2008-000536-40-DEBayer HealthCare AG350
进行中（未招募）
不适用
Pivotal phase III trial to investigate the efficacy and safety of an Orodispersible Tablet vardenafil versus placebo in the treatment of men with Erectile dysfunction (ED) - a fixed-dose, double-blind, raNdomized multi-center Trial - POTENT I - POTENT IErectile Dysfunction (ED)MedDRA version: 9.1Level: LLTClassification code 10061461Term: Erectile dysfunctionEUCTR2008-000536-40-NLBayer HealthCare AG, D-51368 Leverkusen, Germany350